Moe Alsumidaie

http://Moe%20Alsumidaie
Chief Editor
Moe Alsumidaie is Chief Editor of The Clinical Trial Vanguard. Moe holds decades of experience in the clinical trials industry. Moe also serves as Head of Research at CliniBiz and Chief Data Scientist at Annex Clinical Corporation.

Adaptive Clinical Trial Design Adaptive Trial Design Addiction Psychiatry AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Innovation Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy FDA Warning Letter GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials protocol amendments Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression

The Clinical Trial Vanguard
  • Articles
  • Conference Coverage
  • Executive Interviews
  • News
  • CliniCast

Log In

Lost Password?

Latest News

  • CRScube Acquires Mednet to Expand AI-Assisted Data Entry in Clinical Trials 01
    News

    CRScube Acquires Mednet to Expand AI-Assisted Data Entry in Clinical Trials

    October 4, 2026
  • News

    Disconnected systems hinder RBQM adoption in clinical trials, FDA compliance

    October 4, 2026
  • Niia Signature Patch Shows 20-Minute Glucose Signal Recovery After Insulin Bolus 03
    News

    Niia Signature Patch Shows 20-Minute Glucose Signal Recovery After Insulin Bolus

    October 4, 2026
  • DHHS Releases 2026 Unified Agenda With Five Clinical Research Rule Changes 04
    News

    DHHS Releases 2026 Unified Agenda With Five Clinical Research Rule Changes

    October 3, 2026
  • Mineralys to Present Lorundrostat Phase 3 Data at ASN Kidney Week 2026 05
    News

    Mineralys to Present Lorundrostat Phase 3 Data at ASN Kidney Week 2026

    October 3, 2026
  • Teva Presents Post Hoc Ecopipam Data Ahead of 2027 FDA Decision 06
    News

    Teva Presents Post Hoc Ecopipam Data Ahead of 2027 FDA Decision

    October 3, 2026
The Clinical Trial Vanguard
  • ABOUT US
  • Log In
  • Membership Account
    • Membership Billing
    • Membership Cancel
    • Membership Orders
    • Your Profile
  • Membership Checkout
    • Membership Confirmation
  • Membership Levels
  • PRIVACY POLICY
  • SUBSCRIBE
  • TERMS AND CONDITIONS OF ACCESS AND USE
Copyright © 2026 The Clinical Trial Vanguard
  • Articles
  • Conference Coverage
  • Executive Interviews
  • News
  • CliniCast

Start typing and press Enter to search

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}